4D Molecular Therapeutics... (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

3.77

0.33 (9.59%)

At close: May 02, 2025, 3:59 PM

3.72

-1.45%

After-hours: May 02, 2025, 04:54 PM EDT

4D Molecular Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	37K	20.72M	3.13M	18.04M	13.61M	6.99M	14.13M	5.79M
Cost of Revenue	n/a	97.1M	3.88M	3.02M	53.04M	38.72M	18.36M	13.57M
Gross Profit	37K	-76.37M	-751K	15.02M	-39.43M	-31.73M	-4.23M	-7.78M
Operating Income	-187.84M	-112.87M	-110.03M	-71.33M	-56.66M	-50.76M	-10.4M	-11.27M
Interest Income	27.05M	12.21M	2.57M	137K	152K	1.5M	850K	89K
Pretax Income	-160.87M	-100.84M	-107.49M	-71.32M	-56.69M	-49.31M	-9.55M	-11.22M
Net Income	-160.87M	-100.84M	-101.08M	-68.3M	-56.54M	-52.94M	-9.55M	-11.22M
Selling & General & Admin	46.58M	36.49M	32.91M	28.01M	17.24M	13.89M	6.17M	3.49M
Research & Development	141.3M	97.1M	80.25M	61.36M	53.04M	38.72M	18.36M	13.57M
Other Expenses	n/a	n/a	2.54M	16K	-181K	-46K	-2K	-40K
Operating Expenses	187.88M	133.59M	113.16M	89.37M	70.28M	52.61M	24.53M	17.06M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	187.88M	133.59M	113.16M	89.37M	70.28M	52.61M	24.53M	17.06M
Income Tax Expense	n/a	n/a	-6.42M	-3.02M	-152K	3.63M	848K	-89K
Shares Outstanding (Basic)	53.94M	39.13M	32.35M	27.73M	26.68M	26.49M	12.52M	14.84M
Shares Outstanding (Diluted)	53.94M	39.13M	32.35M	27.73M	26.68M	26.49M	12.52M	14.84M
EPS (Basic)	-2.98	-2.58	-3.12	-2.46	-2.12	-2	-0.76	-0.76
EPS (Diluted)	-2.98	-2.58	-3.12	-2.46	-2.12	-2	-0.76	-0.76
EBITDA	-187.84M	-107.12M	-106.15M	-68.31M	-55.22M	-44.62M	-9.7M	-10.65M
EBIT	-187.84M	-112.87M	-110.03M	-71.33M	-56.66M	-45.63M	-10.4M	-11.27M
Depreciation & Amortization	n/a	5.75M	3.88M	3.02M	1.44M	1M	697K	626K